FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367677539> ?p ?o ?g. }

• W4367677539 abstract "It is possible to calculate the number of years to the expected clinical onset (YECO) of autosomal-dominant Alzheimer's disease (adAD). A similar time scale is lacking for sporadic Alzheimer's disease (sAD). The purpose was to design and validate a time scale in YECO for patients with sAD in relation to CSF and PET biomarkers.Patients diagnosed with Alzheimer's disease (AD, n = 48) or mild cognitive impairment (MCI, n = 46) participated in the study. They underwent a standardized clinical examination at the Memory clinic, Karolinska University Hospital, Stockholm, Sweden, which included present and previous medical history, laboratory screening, cognitive assessment, CSF biomarkers (Aβ42, total-tau, and p-tau), and an MRI of the brain. They were also assessed with two PET tracers, 11C-Pittsburgh compound B and 18F-fluorodeoxyglucose. Assuming concordance of cognitive decline in sAD and adAD, YECO for these patients was calculated using equations for the relationship between cognitive performance, YECO, and years of education in adAD (Almkvist et al. J Int Neuropsychol Soc 23:195-203, 2017).The mean current point of disease progression was 3.2 years after the estimated clinical onset in patients with sAD and 3.4 years prior to the estimated clinical onset in patients with MCI, as indicated by the median YECO from five cognitive tests. The associations between YECO and biomarkers were significant, while those between chronological age and biomarkers were nonsignificant. The estimated disease onset (chronological age minus YECO) followed a bimodal distribution with frequency maxima before (early-onset) and after (late-onset) 65 years of age. The early- and late-onset subgroups differed significantly in biomarkers and cognition, but after control for YECO, this difference disappeared for all except the APOE e4 gene (more frequent in early- than in late-onset).A novel time scale in years of disease progression based on cognition was designed and validated in patients with AD using CSF and PET biomarkers. Two early- and late-disease onset subgroups were identified differing with respect to APOE e4." @default.
• W4367677539 created "2023-05-03" @default.
• W4367677539 creator A5087294774 @default.
• W4367677539 creator A5089411086 @default.
• W4367677539 date "2023-05-02" @default.
• W4367677539 modified "2023-09-30" @default.
• W4367677539 title "A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s disease" @default.
• W4367677539 cites W1486380975 @default.
• W4367677539 cites W1687656967 @default.
• W4367677539 cites W1717161387 @default.
• W4367677539 cites W1945463512 @default.
• W4367677539 cites W1954269448 @default.
• W4367677539 cites W1966879670 @default.
• W4367677539 cites W1969204112 @default.
• W4367677539 cites W1976133119 @default.
• W4367677539 cites W2013884279 @default.
• W4367677539 cites W2036362108 @default.
• W4367677539 cites W2047301935 @default.
• W4367677539 cites W2055649795 @default.
• W4367677539 cites W2075444764 @default.
• W4367677539 cites W2089249114 @default.
• W4367677539 cites W2102711224 @default.
• W4367677539 cites W2105756312 @default.
• W4367677539 cites W2116709840 @default.
• W4367677539 cites W2121584008 @default.
• W4367677539 cites W2122280897 @default.
• W4367677539 cites W2129497119 @default.
• W4367677539 cites W2143080879 @default.
• W4367677539 cites W2144021643 @default.
• W4367677539 cites W2151889964 @default.
• W4367677539 cites W2156220037 @default.
• W4367677539 cites W2171250577 @default.
• W4367677539 cites W2194056977 @default.
• W4367677539 cites W2194915957 @default.
• W4367677539 cites W2275920323 @default.
• W4367677539 cites W2324271630 @default.
• W4367677539 cites W2492045666 @default.
• W4367677539 cites W2552733802 @default.
• W4367677539 cites W2573673067 @default.
• W4367677539 cites W2592724277 @default.
• W4367677539 cites W2599190942 @default.
• W4367677539 cites W2626772746 @default.
• W4367677539 cites W2752570168 @default.
• W4367677539 cites W2789710144 @default.
• W4367677539 cites W2794410616 @default.
• W4367677539 cites W2798054687 @default.
• W4367677539 cites W2899192510 @default.
• W4367677539 cites W2912263089 @default.
• W4367677539 cites W2922380399 @default.
• W4367677539 cites W2953848130 @default.
• W4367677539 cites W2960994232 @default.
• W4367677539 cites W2963081245 @default.
• W4367677539 cites W2995770731 @default.
• W4367677539 cites W3006513902 @default.
• W4367677539 cites W3034479818 @default.
• W4367677539 cites W3036672623 @default.
• W4367677539 cites W3093546635 @default.
• W4367677539 cites W3098837201 @default.
• W4367677539 cites W3210285188 @default.
• W4367677539 cites W3215732792 @default.
• W4367677539 cites W4210650500 @default.
• W4367677539 cites W4247665917 @default.
• W4367677539 doi "https://doi.org/10.1186/s13195-023-01231-8" @default.
• W4367677539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37131241" @default.
• W4367677539 hasPublicationYear "2023" @default.
• W4367677539 type Work @default.
• W4367677539 citedByCount "0" @default.
• W4367677539 crossrefType "journal-article" @default.
• W4367677539 hasAuthorship W4367677539A5087294774 @default.
• W4367677539 hasAuthorship W4367677539A5089411086 @default.
• W4367677539 hasBestOaLocation W43676775391 @default.
• W4367677539 hasConcept C126322002 @default.
• W4367677539 hasConcept C143998085 @default.
• W4367677539 hasConcept C160798450 @default.
• W4367677539 hasConcept C185592680 @default.
• W4367677539 hasConcept C187212893 @default.
• W4367677539 hasConcept C2776656118 @default.
• W4367677539 hasConcept C2779134260 @default.
• W4367677539 hasConcept C2779483572 @default.
• W4367677539 hasConcept C2780906993 @default.
• W4367677539 hasConcept C2781197716 @default.
• W4367677539 hasConcept C2984863031 @default.
• W4367677539 hasConcept C502032728 @default.
• W4367677539 hasConcept C55493867 @default.
• W4367677539 hasConcept C71924100 @default.
• W4367677539 hasConceptScore W4367677539C126322002 @default.
• W4367677539 hasConceptScore W4367677539C143998085 @default.
• W4367677539 hasConceptScore W4367677539C160798450 @default.
• W4367677539 hasConceptScore W4367677539C185592680 @default.
• W4367677539 hasConceptScore W4367677539C187212893 @default.
• W4367677539 hasConceptScore W4367677539C2776656118 @default.
• W4367677539 hasConceptScore W4367677539C2779134260 @default.
• W4367677539 hasConceptScore W4367677539C2779483572 @default.
• W4367677539 hasConceptScore W4367677539C2780906993 @default.
• W4367677539 hasConceptScore W4367677539C2781197716 @default.
• W4367677539 hasConceptScore W4367677539C2984863031 @default.
• W4367677539 hasConceptScore W4367677539C502032728 @default.
• W4367677539 hasConceptScore W4367677539C55493867 @default.
• W4367677539 hasConceptScore W4367677539C71924100 @default.
• W4367677539 hasFunder F4320322315 @default.

• next